Vivos Therapeutics, Inc says 2022 and early 2023 accomplishments sets stage for potential revenue growth this year
Vivos Therapeutics (NASDAQ:VVOS), Inc has announced its fiscal 2022 financial results and provided an operational update, saying it believes its 2022 and...
Source: proactiveinvestors.com